HUIZHONG NEWS

Amid sweeping industry transformation, where should we go? Combined vaccines lead the way in scientifically reducing the burden of disease prevention and control—Huizhong Bio’s new formulation launch event.

(Xinmu Net, reported from Luoyang) At present, China’s poultry industry is rapidly advancing toward “large-scale production, standardization, intelligent management, and ecological sustainability.” However, persistent outbreaks of disease, unregulated use of preventive and therapeutic medications, and increasingly complex vaccination protocols remain significant challenges hindering the sector’s rapid development. How to achieve “scientific burden reduction and healthy farming” has become a pressing issue that the industry must address. On July 6, 2017, Luoyang Huizhong Biotechnology Co., Ltd. (hereinafter referred to as Huizhong Biotechnology) convened in Luoyang, Henan, a forum on a new immunization model—“Scientific Burden Reduction, Win-Win Cooperation”—alongside a launch event for its newly developed Flow‑Based Method, inviting industry professionals from across the country.

2017-07-09

A spirited debate on the industry, with wings of dreams soaring into the future.

In response to the new landscape shaped by the internet, capital investment, and modern animal husbandry, as well as the current state of development in the veterinary biologics industry, the Biologics Sub‑Forum of the High‑Level Forum on Veterinary Drug Industry Development and Livestock Product Safety held a face-to-face interactive session on the afternoon of the 16th. The session was chaired by Hu Qiyi, Chairman of China Animal Health Products Co., Ltd., and featured presentations by Gu Hong, Director of the Pharmaceutical Administration Division of the Veterinary Bureau of the Ministry of Agriculture; Li Wanmeng, Executive General Manager of Merial China; Sun Jinzhong, General Manager of Placor Bioengineering Co., Ltd.; Xiang Huixing, Chairman of Beijing Zhonglian Kang Biotechnology Co., Ltd.; Sun Hao, Chairman of Beijing Huadu Yupin Poultry Co., Ltd.; Wang Yongsheng, General Manager of Jinyu Baoling Biological Pharmaceutical Co., Ltd.; and Qingdao…

2015-09-23

Industry Leaders “Decipher” the Future Trends of Veterinary Chemical Pharmaceuticals

On the afternoon of September 16, the Chemical Pharmaceuticals and Traditional Chinese Veterinary Medicine Sub‑Forum of the High‑Level Forum on Veterinary Drug Industry Development and Livestock Product Safety was solemnly convened in the VIP Hall on the third floor of the Luoyang Modu Lihao International Hotel. Li Xiangdong, Vice President of the China Veterinary Drug Association, delivered a speech, expressing gratitude for the strong support from the Veterinary Bureau, the National Institute for Food and Drug Control, and the Henan Provincial Bureau, as well as for the enthusiastic participation of the heads of leading veterinary drug companies and all corporate representatives in attendance. He emphasized that the central theme of the conference is “innovation”—namely, innovation in science and technology, management, and economic marketing—and that innovative concepts and ways of thinking are the driving force behind the industry’s development. Xu Shixin, Director of the Safety Evaluation Department at the China Institute of Veterinary Drug Supervision, provided an in-depth analysis of the “antibiotic ban.”

2015-09-23

< 1 >